ExposeIQ expands JuryFit for medical malpractice jury selection
ExposeIQ said it has added capabilities to its JuryFit platform to help trial teams analyze juror factors and build more structured voir dire strategies in medical malpractice cases. The company says the tool is meant to support high-stakes jury selection by pairing data analysis with human verification.
Why it matters: - Medical malpractice trials often turn on how jurors weigh complex medical evidence, expert testimony and personal beliefs about healthcare accountability. - ExposeIQ is pitching JuryFit as a way for trial teams to bring more structure to jury selection in cases where juror bias or life experience can shape liability outcomes. - The platform is aimed at helping attorneys make more informed decisions before and during voir dire.
What happened: - ExposeIQ announced expanded capabilities in its JuryFit platform for medical malpractice litigation. - The company said the update is designed to help trial attorneys approach jury selection with greater structure in complex medical liability cases. - Joseph Terp, ExposeIQ co-founder and CEO, said the platform is built to provide greater clarity during jury selection while keeping human oversight in place.
The details: - JuryFit analyzes case theories against juror dimensions that include demographic factors, life experiences, attitudes and beliefs, political and social values, personality and cognitive traits, and implicit and explicit biases. - The platform looks for combinations of those factors that may shape how jurors respond to allegations of medical negligence and standard of care. - All assessments are subject to human verification by licensed professionals. - JuryFit generates targeted voir dire questions based on the evaluation. - Those questions also undergo human verification before use. - After a jury is seated, the platform can test key arguments, expert testimony themes and damages presentations against a Virtual Mirror Jury™. - ExposeIQ says the simulation is built to reflect the personality profiles and group dynamics of the actual seated jurors. - All outputs from the Virtual Mirror Jury process are reviewed through human verification. - ExposeIQ said the platform is intended to support more consistent jury selection in complex medical liability matters while preserving full professional judgment over final decisions.
Between the lines: - The product update reflects growing demand for tools that try to systematize jury analysis in cases where verdicts can hinge on subtle juror attitudes rather than only legal arguments. - The repeated emphasis on human verification suggests ExposeIQ is positioning the software as decision support, not an automated replacement for trial strategy. - The focus on medical malpractice also signals a narrower use case than general litigation analytics.
What's next: - ExposeIQ is likely to market JuryFit to plaintiff and defense trial teams handling medical negligence disputes. - The company’s broader litigation intelligence tools will continue to center on combining technology with professional oversight. - More information is available on the company’s LinkedIn profile and X account.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
Political Press Watch
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.